Search research articles
Contact Us
Filters
Showing results (321-330 of 878) with videos related to
Page
of 88
Sort By:
Internal Medicine Journal
|
April 25, 2026
Hypocomplementaemic urticarial vasculitis with mesangioproliferative glomerulonephritis, interstitial nephritis and absent immune staining
Cindy-Anne T Bach, David A Power, David S Williams, et al.
Techniques in Hand & Upper Extremity Surgery
|
November 26, 2019
The Triceps Traction Test: A Decision Tool for the Choice of Stabilizing Flap After In Situ Decompression of the Ulnar Nerve
Matthew W T Curran, Hollie A Power, K Ming Chan, et al.
Kidney International
|
May 9, 1998
Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy
K Paizis, G Kirkland, M Polihronis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
August 8, 2014
A novel Tn3-like composite transposon harboring blaVIM-1 in Klebsiella pneumoniae spp. pneumoniae isolated from river water
Katrin Zurfluh, Karen A Power, Jochen Klumpp, et al.
Seminars in Immunology
|
December 24, 2002
Strategies for chemokine antagonists as therapeutics
Amanda E I Proudfoot, Christine A Power, Christian Rommel, et al.
Journal of the American College of Cardiology
|
November 26, 2021
Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review
David Sternheim, David A Power, Rajeev Samtani, et al.
Current Protocols in Pharmacology
|
October 1, 2011
Cellular assays of chemokine receptor activation
A E Proudfoot, C A Power, D J Church, et al.
American Journal of Physiology. Renal Physiology
|
February 26, 2010
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
Kenneth R Hallows, Peter F Mount, Núria M Pastor-Soler, et al.
Current Cancer Drug Targets
|
April 8, 2010
CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer
J L Hao, P J Cozzi, A Khatri, et al.
Acta Orthopaedica Scandinavica
|
October 30, 2004
Do we really need to routinely crossmatch blood before primary total knee or hip arthroplasty?
Gary M Mundy, Kate Hardiment, John Revill, et al.
Page
of 88
Search research articles
Search
Showing results (321-330 of 878) with videos related to
Sort By:
Page
of 88
Internal Medicine Journal
|
April 25, 2026
Hypocomplementaemic urticarial vasculitis with mesangioproliferative glomerulonephritis, interstitial nephritis and absent immune staining
Cindy-Anne T Bach, David A Power, David S Williams, et al.
Techniques in Hand & Upper Extremity Surgery
|
November 26, 2019
The Triceps Traction Test: A Decision Tool for the Choice of Stabilizing Flap After In Situ Decompression of the Ulnar Nerve
Matthew W T Curran, Hollie A Power, K Ming Chan, et al.
Kidney International
|
May 9, 1998
Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy
K Paizis, G Kirkland, M Polihronis, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
August 8, 2014
A novel Tn3-like composite transposon harboring blaVIM-1 in Klebsiella pneumoniae spp. pneumoniae isolated from river water
Katrin Zurfluh, Karen A Power, Jochen Klumpp, et al.
Seminars in Immunology
|
December 24, 2002
Strategies for chemokine antagonists as therapeutics
Amanda E I Proudfoot, Christine A Power, Christian Rommel, et al.
Journal of the American College of Cardiology
|
November 26, 2021
Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review
David Sternheim, David A Power, Rajeev Samtani, et al.
Current Protocols in Pharmacology
|
October 1, 2011
Cellular assays of chemokine receptor activation
A E Proudfoot, C A Power, D J Church, et al.
American Journal of Physiology. Renal Physiology
|
February 26, 2010
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
Kenneth R Hallows, Peter F Mount, Núria M Pastor-Soler, et al.
Current Cancer Drug Targets
|
April 8, 2010
CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer
J L Hao, P J Cozzi, A Khatri, et al.
Acta Orthopaedica Scandinavica
|
October 30, 2004
Do we really need to routinely crossmatch blood before primary total knee or hip arthroplasty?
Gary M Mundy, Kate Hardiment, John Revill, et al.
Page
of 88